Pharmaceutical firms urged to report alleged anomalies in FDA

• Published date: 22 November 2022
• Publication title: Philippines News agency

Pharmaceutical companies are urged to report alleged anomalies in the Food and Drug Administration (FDA).

This, after Senator Raffy Tulfo claimed in a Senate hearing last Nov. 18 that some FDA officials are asking PHP5 million to PHP20 million from pharmaceutical companies for the fast-tracking of their products' Certificate of Product Registration (CPR).

In a media briefing, Department of Health (DOH) officer-in-charge Maria Rosario Vergeire said upon the presentation of evidence, the DOH would probe into the FDA's alleged illegal activities.

She added that the DOH is open to discuss issues concerning FDA since it is under the Office of the Health...